Our data provide additional evidence to support the notion that CXCR4 antagonist treatment effectively mobilizes more functional neutrophils, that may, in turn, help patients with WHIM syndrome to overcome the recurrent infections commonly observed. The gene discussed is CXCR4; the disease is infection.